Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Unacylated ghrelin fragments as therapeutic agent in the treatment of obesity

Unacylated ghrelin fragments as therapeutic agent in the treatment of obesity

US Patent 8318664 · Granted Nov 27, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylat2017
Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders2012
Methods for promoting growth and survival of insulin-secreting cells2011
Use of ghrelin and unacylated ghrelin compositions for treating insulin resistan2010
Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses2010
Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses2009